Scarica l'app Stockscreener
1.07
5.31%
-0.06
Dopo l'orario di chiusura:
1.11
0.04
+3.74%
Precedente Chiudi:
$1.13
Aprire:
$1.16
Volume 24 ore:
47,909
Relative Volume:
0.32
Capitalizzazione di mercato:
$2.82M
Reddito:
$8.27M
Utile/perdita netta:
$-17.52M
Rapporto P/E:
-0.0171
EPS:
-62.6089
Flusso di cassa netto:
$-10.90M
1 W Prestazione:
-9.32%
1M Prestazione:
-1.83%
6M Prestazione:
-62.59%
1 anno Prestazione:
+3.86%
Intervallo 1D:
$1.07
$1.16
Intervallo di 1 settimana:
$1.07
$1.22
Portata 52W:
$0.19
$25.95
Nuwellis Inc Stock (NUWE) Company Profile
Nome
Nuwellis Inc
Settore
Industria
Telefono
952-345-4200
Indirizzo
12988 VALLEY VIEW ROAD, EDEN PRAIRIE
Compare NUWE vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NUWE
Nuwellis Inc
|
1.07 | 2.98M | 8.27M | -17.52M | -10.90M | -62.61 |
ABT
Abbott Laboratories
|
89.46 | 158.14B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
294.73 | 120.69B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
80.00 | 103.96B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
56.50 | 85.62B | 20.62B | 3.56B | 3.66B | 2.3847 |
EW
Edwards Lifesciences Corp
|
83.98 | 48.14B | 6.30B | 1.07B | 1.34B | 1.8406 |
Nuwellis Inc Stock (NUWE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-29 | Iniziato | ROTH MKM | Buy |
Nuwellis Inc Borsa (NUWE) Ultime notizie
Nuwellis gains USPTO approval for dual-lumen catheter patent - MSN
Nuwellis (NUWE) awards 6,744 stock options to director Waller - Stock Titan
Nuwellis (NASDAQ: NUWE) director receives 6,744 stock options grant - Stock Titan
Director at Nuwellis (NUWE) granted 6,744 stock options at $1.16 - Stock Titan
Director at Nuwellis (NASDAQ: NUWE) receives 6,744 stock options - Stock Titan
Nuwellis (NASDAQ: NUWE) investors back board nominees and 2026 auditor - Stock Titan
MSN Money - MSN
Nuwellis highlights pediatric ultrafiltration case study at ISHLT By Investing.com - Investing.com South Africa
Nuwellis highlights pediatric ultrafiltration case study at ISHLT - Investing.com
When drugs failed, a child heart-failure case turned to fluid removal - Stock Titan
Nuwellis (NUWE) Secures Patent Approval for Innovative Catheter Technology - GuruFocus
Nuwellis receives patent allowance for dual lumen catheter - Investing.com
Nuwellis receives patent allowance for dual lumen catheter By Investing.com - Investing.com Australia
Nuwellis Announces Receipt of a Notice of Allowance from the U.S. Patent and Trademark Office for Innovative Dual Lumen Midline Catheter Technology - The Manila Times
Catheter cut to fit at bedside gets USPTO allowance for Nuwellis - Stock Titan
Nuwellis Stock Rises After Hours Following Patent Win For Blood Filtering System — Retail Mood Turns Buoyant - MSN
NUWE Price Today: Nuwellis, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
Nuwellis, Inc. Files Form 8-K with SEC: Company Details, Stock Information, and Executive Signature - Minichart
Nuwellis Settles Lawsuit With E.F. Hutton, Resolving Dispute - TipRanks
Nuwellis (NUWE) to pay $204,000 to settle E.F. Hutton lawsuit - Stock Titan
Nuwellis Updates Software for Aquadex SmartFlow Ultrafiltration Platform - Diagnostic and Interventional Cardiology
NUWE Stock Price, Quote & Chart | NUWELLIS INC (NASDAQ:NUWE) - ChartMill
Nuwellis to Participate in the AATS 106th Annual Meeting and ERAS Cardiac Spring Retreat - The Manila Times
Chicago heart-surgery meeting puts Nuwellis' fluid-removal system on display - Stock Titan
Nuwellis releases software update for Aquadex ultrafiltration system By Investing.com - Investing.com India
Nuwellis releases software update for Aquadex ultrafiltration system - Investing.com
Nuwellis announces Aquadex software update - marketscreener.com
Nuwellis Announces Aquadex Software Update - marketscreener.com
Nuwellis halves Aquadex fluid-adjustment steps for pediatric patients - Stock Titan
Nuwellis (NUWE) Stock: Trending Down? (Volatility Increases) 2026-04-18Trending Social Stocks - Cổng thông tin điện tử Tỉnh Sơn La
Nuwellis (NUWE) Welcomes Back Key Team Members - GuruFocus
Nuwellis Welcomes Back Three Former Team Members to Accelerate Commercial and Clinical Momentum - marketscreener.com
Three former Nuwellis employees return as Aquadex expansion pushes on - Stock Titan
Is Nuwellis (NUWE) Stock a Value Play | NUWE Q4 Earnings: Beats Estimates by $0.09Catalyst Event - Cổng thông tin điện tử tỉnh Tây Ninh
Does Nuwellis (NUWE) Stock pay reliable income | Price at $1.10, Up 1.85%Verified Analyst Reports - Xã Châu Thành
Nuwellis retains CORE IR for investor relations services By Investing.com - Investing.com India
Nuwellis Engages CORE IR for Public Relations, Shareholder Communications, and Social Media Management Services - Bitget
Nuwellis brings in CORE IR to sharpen investor outreach and social media - Stock Titan
Is Nuwellis (NUWE) Stock Overpriced Now | Price at $1.10, Up 1.85%Market Hype Signals - Xã Vĩnh Công
Should I Buy Nuwellis (NUWE) Stock in 2026 | Price at $1.14, Up 0.88%Stock Trading Network - Cổng thông tin điện tử tỉnh Lào Cai
Nuwellis, Inc. (NUWE) stock price, news, quote and history - Yahoo Finance UK
Nuwellis Strengthens Commercial Infrastructure with New South Texas Territory - Bitget
Can Nuwellis Inc stock double in the next yearQuarterly Profit Review & Community Consensus Trade Alerts - baoquankhu1.vn
Nuwellis (NUWE) Expands Commercial Reach in South Texas - GuruFocus
Nuwellis Inc Strengthens Commercial Infrastructure with New South Texas Territory - marketscreener.com
Nuwellis signs letter of intent to acquire Rendiatech - MSN
Nuwellis (NASDAQ: NUWE) outlines 2026 virtual meeting, director elections and auditor ratification - Stock Titan
Nuwellis, Inc. Form 8-K/A Filing Details, Company Information, and SEC Compliance Disclosures - Minichart
Former Nuwellis (NASDAQ: NUWE) directors submit response letters - Stock Titan
Nuwellis Inc Azioni (NUWE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.57%
1.14%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):